Pyridin-2-ylmethyl 2-(4-isobutylphenyl)propanoate

Catalog No. :
ACMLZE738
CAS No. :
64622-45-3
Molecular Formula :
C19H23NO2
Molecular Weight :
297.40

IUPAC Name:pyridin-2-ylmethyl 2-(4-isobutylphenyl)propanoate

Pyridin-2-ylmethyl 2-(4-isobutylphenyl)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$96.00Login to see priceIn stockIn stock
10g95%$144.00Login to see priceIn stockIn stock
25g95%$287.00Login to see priceIn stockIn stock
100g95%$1113.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePyridin-2-ylmethyl 2-(4-isobutylphenyl)propanoate
IUPAC Namepyridin-2-ylmethyl 2-(4-isobutylphenyl)propanoate
MDL No.MFCD00866018
Molecular FormulaC19H23NO2
Molecular Weight297.40
SMILESCC(C1=CC=C(CC(C)C)C=C1)C(OCC2=NC=CC=C2)=O
InChI KeyACEWLPOYLGNNHV-UHFFFAOYSA-N
Synonymibuprofen piconol | 64622-45-3 | Pimeprofen | Staderm | IBUPROFENPICONOL | Vesicum | 112017-99-9 | pyridin-2-ylmethyl 2-(4-isobutylphenyl)propanoate | 2-Pyridylmethyl 2-(4-isobutylphenyl)propionate | pyridin-2-ylmethyl 2-[4-(2-methylpropyl)phenyl]propanoate | BE-100 | B0F91K5U
CAS No.64622-45-3
PubChem CID3673

Synthetic Route by SureRoute

1. ACMLZE738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQELN480 route compound structure diagram
    ACQELN48034715-60-1 In Stock
  2. Plus
  3. ACUMDR625 route compound structure diagram
    ACUMDR625586-98-1 In Stock
  4. Then
  5. ACMLZE738 route product structure diagram
    ACMLZE73864622-45-3 In Stock
Inquiry

2. ACMLZE738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXVF473 route compound structure diagram
    ACAXVF47315687-27-1 In Stock
  2. Plus
  3. ACUMDR625 route compound structure diagram
    ACUMDR625586-98-1 In Stock
  4. Then
  5. ACMLZE738 route product structure diagram
    ACMLZE73864622-45-3 In Stock
Inquiry

Comments (0)